EXTENDED ENDOCRINE PUBLICATIONS & ABSTRACTS
Extended Endocrine data
Evidence / Extended Endocrine
Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy: A Secondary Analysis of the IDEAL Randomized Clinical Trial
Title: Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy: A Secondary Analysis of the IDEAL Randomized Clinical Trial Publication: JAMA Network Open. 2024;7(11):e2447530. Authors: Laura J. van ’t Veer, PhD; Elma Meershoek-Klein Kranenbarg, MS; Marjolijn Duijm-de Carpentier, BS; Cornelis J. H. Van de Velde, MD; Miranda Read More
NSABP B-42 Trial shows MammaPrint Low Risk is Predictive of EET – JCO Publication
Journal of Clinical Oncology, July 24, 2024 Authors: Rastogi, et al.
Read MoreGene-expression assays to tailor adjuvant endocrine therapy
Clinical Cancer Research, Vol 30, Issue 14, July 15 2024 Author: Bottosso et al.
Read MoreIDEAL Trial: MammaPrint Utility for Prediction of Extended Endocrine Therapy, SABCS 2022
IDEAL Trial, GS5-10, SABCS 2022 Authors: Liefers, et al.
Read MoreSTO-5 Trial: 20-yr benefit from Adjuvant Goserelin & Tamoxifen, JCO 2022
Journal of Clinical Oncology, 40:4071-4082 Authors: Johansson et al.
Read MoreB-42 Trial: MammaPrint Utility for Prediction of Extended Letrozole Therapy, ASCO 2021
NSABP B-42 Trial, ASCO 2021 Abstract #502 Authors: Rastogi, et al.
Read More
